FGF21 is a crucial mediator in the adaptive metabolic response to starvation, and is an excellent therapeutic molecule for treatment of type 2 diabetes and obesity in rodents and monkeys. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.